Citation: Bo Hu, Sudong Kong, Yuhua Weng, Deyao Zhao, Abid Hussain, Qingze Jiao, Shijing Zhan, Ling Qiu, Jianguo Lin, Minhao Xie, Bo Li, Yuanyu Huang. Lipid-conjugated siRNA hitchhikes endogenous albumin for tumor immunotherapy[J]. Chinese Chemical Letters, ;2023, 34(11): 108210. doi: 10.1016/j.cclet.2023.108210 shu

Lipid-conjugated siRNA hitchhikes endogenous albumin for tumor immunotherapy

Bo Hu ^{a, 1} ,
Sudong Kong ^{b, c, 1} ,
Yuhua Weng ^a ,
Deyao Zhao ^{a, d} ,
Abid Hussain ^a ,
Qingze Jiao ^e ,
Shijing Zhan ^e ,
Ling Qiu ^{b, c} ,
Jianguo Lin ^c ,
Minhao Xie ^{b, c, *,} ,
Bo Li ^{a, **,} ,
Yuanyu Huang ^{a, e, f, **,}

a.
School of Life Science; Advanced Research Institute of Multidisciplinary Science; School of Medical Technology; Key Laboratory of Molecular Medicine and Biotherapy; Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering; Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, Beijing Institute of Technology, Beijing 100081, China
b.
School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China
c.
NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China
d.
Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
e.
School of Materials and the Environment, Beijing Institute of Technology, Zhuhai 519085, China
f.
Rigerna Therapeutics, Suzhou 215127, China

^**

xieminhao@jsinm.org

boli@bit.edu.cn

yyhuang@bit.edu.cn

Received Date: 24 November 2022
Revised Date: 3 February 2023
Accepted Date: 9 February 2023
Available Online: 11 February 2023

Figures(6)

With the development of a small interfering RNA (siRNA) delivery strategy, increasing siRNA therapeutics for tumor treatment appeared in clinical trials and pre-clinical development. However, the test results of such therapeutics unveiled that efficient siRNA delivery to tumor tissues is still challenging. Albumin is considered an ideal carrier for delivering hydrophobic agents into tumor tissue because it is highly concentrated and long-circulating in blood and has propensity of tumor enrichment. Herein, we synthesized lipid conjugated siRNAs (LsiRNAs), which showed high affinity to albumin. Mechanistically, LsiRNAs non-covalently bind to the hydrophobic core of albumin through its octadecyl tails. The small size of albumin/LsiRNAs allows the complex to penetrate tumor tissue efficiently. Biodistribution test proved that albumin extremely prolonged circulation time and increased tumor retention of associated LsiRNAs. Notably, LsiRNA against programmed death ligand-1 (Pdl1) efficiently suppressed tumor growth as well as prolonged survival time of tumor bearing mice by increasing infiltration of CD8⁺ T cells as well as promoted the maturation of dendritic cells both in tumor and lymph. Together, LsiRNAs provide a simple but effective way for siRNA tumor delivery that “hitchhikes” on albumin.
- Albumin,
- siRNA,
- Lipid conjugate,
- Tumor treatment,
- Immunotherapy
1. [1]
  Y. Weng, H. Xiao, J. Zhang, et al., Biotechnol. Adv. 37 (2019) 801–825. doi: 10.1016/j.biotechadv.2019.04.012
2. [2]
  A. Wittrup, J. Lieberman, Nat. Rev. Genet. 16 (2015) 543–552. doi: 10.1038/nrg3978
3. [3]
  K. Li, M. Lu, X. Xia, et al., Chin. Chem. Lett. 32 (2021) 1010–1016. doi: 10.1016/j.cclet.2020.09.010
4. [4]
  S. Guo, K. Li, B. Hu, et al., Exploration 1 (2021) 35–49. doi: 10.1002/exp.20210008
5. [5]
  B. Hu, B. Li, K. Li, et al., Sci. Adv. 8 (2022) eabm1418. doi: 10.1126/sciadv.abm1418
6. [6]
  M. Jayaraman, S.M. Ansell, B.L. Mui, et al., Angew. Chem. Int. Ed. 51 (2012) 8529–8533. doi: 10.1002/anie.201203263
7. [7]
  E. Khvalevsky, R. Gabai, I.H. Rachmut, et al., Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 20723–20728. doi: 10.1073/pnas.1314307110
8. [8]
  J. Zhou, Y. Wu, C. Wang, et al., Nano Lett. 16 (2016) 6916–6923. doi: 10.1021/acs.nanolett.6b02915
9. [9]
  A. Ellert-Miklaszewska, N. Ochocka, M. Maleszewska, et al., Nanomedicine 14 (2019) 2441–2458. doi: 10.2217/nnm-2019-0176
10. [10]
  J. Liu, C. Chen, T. Wei, et al., Exploration 1 (2021) 21–34. doi: 10.1002/EXP.20210003
11. [11]
  S. Kamerkar, V.S. LeBleu, H. Sugimoto, et al., Nature 546 (2017) 498–503. doi: 10.1038/nature22341
12. [12]
  Y. Huang, Q. Cheng, X. Jin, et al., Biomater. Sci. 4 (2016) 494–510. doi: 10.1039/C5BM00429B
13. [13]
  Y. Huang, X. Wang, W. Huang, et al., Sci. Rep. 5 (2015) 12458. doi: 10.1038/srep12458
14. [14]
  S.S. Kim, C. Ye, P. Kumar, et al., Mol. Ther. 18 (2010) 993–1001. doi: 10.1038/mt.2010.27
15. [15]
  P. Kumar, H. Wu, J.L. McBride, et al., Nature 448 (2007) 39–43. doi: 10.1038/nature05901
16. [16]
  M. Li, C. Wang, Z. Di, et al., Angew. Chem. Int. Ed. 58 (2019) 1350–1354. doi: 10.1002/anie.201810735
17. [17]
  B. Liu, F. Hu, J. Zhang, et al., Angew. Chem. Int. Ed. 58 (2019) 8804–8808. doi: 10.1002/anie.201903417
18. [18]
  Y. Liu, J. Zhang, Y. Guo, et al., Exploration 2 (2022) 20210172. doi: 10.1002/EXP.20210172
19. [19]
  S. Guo, B. Liu, M. Zhang, et al., Chin. Chem. Lett. 32 (2021) 102–106. doi: 10.1016/j.cclet.2020.11.024
20. [20]
  M. Caillaud, M. El Madani, L. Massaad-Massade, J. Control. Release 321 (2020) 616–628. doi: 10.1016/j.jconrel.2020.02.032
21. [21]
  T.M. Allen, P.R. Cullis, Adv. Drug Deliv. Rev. 65 (2013) 36–48. doi: 10.1016/j.addr.2012.09.037
22. [22]
  O. Khorev, D. Stokmaier, O. Schwardt, et al., Bioorg. Med. Chem. 16 (2008) 5216–5231. doi: 10.1016/j.bmc.2008.03.017
23. [23]
  B. Hu, L. Zhong, Y. Weng, et al., Signal Transduct. Target. Ther. 5 (2020) 101. doi: 10.1038/s41392-020-0207-x
24. [24]
  K.M. Brown, J.K. Nair, M.M. Janas, et al., Nat. Biotechnol. 40 (2022) 1500–1508. doi: 10.1038/s41587-022-01334-x
25. [25]
  E. Neumann, E. Frei, D. Funk, et al., Expert Opin. Drug Deliv. 7 (2010) 915–925. doi: 10.1517/17425247.2010.498474
26. [26]
  C. Ji, X. Guo, Nat. Rev. Endocrinol. 15 (2019) 731–743. doi: 10.1038/s41574-019-0260-0
27. [27]
  E.N. Hoogenboezem, C.L. Duvall, Adv. Drug Deliv. Rev. 130 (2018) 73–89. doi: 10.1016/j.addr.2018.07.011
28. [28]
  Y. Zhao, C. Cai, M. Liu, et al., Int. J. Biol. Macromol. 153 (2020) 873–882. doi: 10.1016/j.ijbiomac.2020.03.060
29. [29]
  G. Wang, Z. Zhou, Z. Zhao, et al., ACS Nano 14 (2020) 4890–4904. doi: 10.1021/acsnano.0c00974
30. [30]
  H. Dong, S.E. Strome, D.R. Salomao, et al., Nat. Med. 8 (2002) 793–800. doi: 10.1038/nm730
31. [31]
  M.J. Butte, M.E. Keir, T.B. Phamduy, et al., Immunity 27 (2007) 111–122. doi: 10.1016/j.immuni.2007.05.016
32. [32]
  J.J. Park, R. Omiya, Y. Matsumura, et al., Blood 116 (2010) 1291–1298. doi: 10.1182/blood-2010-01-265975
33. [33]
  B. Hu, Y. Weng, X.H. Xia, et al., J. Gene Med. 21 (2019) e3097. doi: 10.1002/jgm.3097
34. [34]
  R. Liu, C. Luo, Z. Pang, et al., Chin. Chem. Lett. 34 (2023) 107518. doi: 10.1016/j.cclet.2022.05.032
35. [35]
  S. Wilhelm, A.J. Tavares, Q. Dai, et al., Nat. Rev. Mater. 1 (2016) 16014. doi: 10.1038/natrevmats.2016.14
36. [36]
  F. Danhier, J. Control. Release 244 (2016) 108–121. doi: 10.1016/j.jconrel.2016.11.015
37. [37]
  J.W. Nichols, Y.H. Bae, J. Control. Release 190 (2014) 451–464. doi: 10.1016/j.jconrel.2014.03.057
38. [38]
  M.N. Kundranda, J. Niu, Drug Des. Dev. Ther. 9 (2015) 3767–3777. doi: 10.2147/DDDT.S88023
39. [39]
  J. Hu, X. Yuan, F. Wang, et al., Chin. Chem. Lett. 32 (2021) 1341–1347. doi: 10.1016/j.cclet.2020.11.006
40. [40]
  W. Song, Z. Tang, N. Shen, et al., J. Control. Release 231 (2016) 94–102. doi: 10.1016/j.jconrel.2016.02.039
41. [41]
  W. Song, Z. Tang, D. Zhang, et al., Small 11 (2015) 3755–3761. doi: 10.1002/smll.201500324
42. [42]
  L. Tang, X. Yang, Q. Yin, et al., Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 15344–15349. doi: 10.1073/pnas.1411499111
43. [43]
  S. Qin, B.Z. Fite, M.K. Gagnon, et al., Ann. Biomed. Eng. 42 (2014) 280–298. doi: 10.1007/s10439-013-0895-2
44. [44]
  Q. Sun, Z. Zhou, N. Qiu, et al., Adv. Mater. 29 (2017) 201606628.
1. [1]
  Luyu Zhang , Zirong Dong , Shuai Yu , Guangyue Li , Weiwen Kong , Wenjuan Liu , Haisheng He , Yi Lu , Wei Wu , Jianping Qi . Ionic liquid-based in situ dynamically self-assembled cationic lipid nanocomplexes (CLNs) for enhanced intranasal siRNA delivery. Chinese Chemical Letters, 2024, 35(7): 109101-. doi: 10.1016/j.cclet.2023.109101
2. [2]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
3. [3]
  Yongkang Yue , Zhou Xu , Kaiqing Ma , Fangjun Huo , Xuemei Qin , Kuanshou Zhang , Caixia Yin . HSA shrinkage optimizes the photostability of embedded dyes fundamentally to amplify their efficiency as photothermal materials. Chinese Chemical Letters, 2024, 35(8): 109223-. doi: 10.1016/j.cclet.2023.109223
4. [4]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
5. [5]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
6. [6]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
7. [7]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
8. [8]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
9. [9]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
10. [10]
  Peide Zhu , Yangjia Liu , Yaoyao Tang , Siqi Zhu , Xinyang Liu , Lei Yin , Quan Liu , Zhiqiang Yu , Quan Xu , Dixian Luo , Juncheng Wang . Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chemical Letters, 2024, 35(4): 108689-. doi: 10.1016/j.cclet.2023.108689
11. [11]
  Zhigang Zeng , Changzhou Liao , Lei Yu . Molecules for COVID-19 treatment. Chinese Chemical Letters, 2024, 35(7): 109349-. doi: 10.1016/j.cclet.2023.109349
12. [12]
  Jiqing Liu , Qi Dang , Liting Wang , Dejin Wang , Liang Tang . Applications of flexible electrochemical electrodes in wastewater treatment: A review. Chinese Chemical Letters, 2024, 35(8): 109277-. doi: 10.1016/j.cclet.2023.109277
13. [13]
  Xing Tian , Di Wu , Wanheng Wei , Guifu Dai , Zhanxian Li , Benhua Wang , Mingming Yu . A lipid droplets-targetable fluorescent probe for polarity detection in cells of iron death, inflammation and fatty liver tissue. Chinese Chemical Letters, 2024, 35(6): 108912-. doi: 10.1016/j.cclet.2023.108912
14. [14]
  Lu Li , Suticha Chunta , Xianzi Zheng , Haisheng He , Wei Wu , Yi Lu . β-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis. Chinese Chemical Letters, 2024, 35(4): 108662-. doi: 10.1016/j.cclet.2023.108662
15. [15]
  Fengkai Zou , Borui Su , Han Leng , Nini Xin , Shichao Jiang , Dan Wei , Mei Yang , Youhua Wang , Hongsong Fan . Red-emissive carbon quantum dots minimize phototoxicity for rapid and long-term lipid droplet monitoring. Chinese Chemical Letters, 2024, 35(10): 109523-. doi: 10.1016/j.cclet.2024.109523
16. [16]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
17. [17]
  Tong Zhang , Chao Sun , Shubin Yang , Zimin Cai , Sifeng Zhu , Wendian Liu , Yun Luan , Cheng Wang . Inhalation of taraxasterol loaded mixed micelles for the treatment of idiopathic pulmonary fibrosis. Chinese Chemical Letters, 2024, 35(8): 109248-. doi: 10.1016/j.cclet.2023.109248
18. [18]
  Wenhao Chen , Jian Du , Hanbin Zhang , Hancheng Wang , Kaicheng Xu , Zhujun Gao , Jiaming Tong , Jin Wang , Junjun Xue , Ting Zhi , Longlu Wang . Surface treatment of GaN nanowires for enhanced photoelectrochemical water-splitting. Chinese Chemical Letters, 2024, 35(9): 109168-. doi: 10.1016/j.cclet.2023.109168
19. [19]
  Wenlong Li , Feishi Shan , Qingdong Bao , Qinghua Li , Hua Gao , Leyong Wang . Supramolecular assembly nanoparticle for trans-epithelial treatment of keratoconus. Chinese Chemical Letters, 2024, 35(10): 110060-. doi: 10.1016/j.cclet.2024.110060
20. [20]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727

Get Citation

PDF

XML

Metrics

PDF Downloads(9)
Abstract views(455)
HTML views(10)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142